OMRF and Stanford have received a four-year grant to use zebrafish to study how small genetic variations can lead to several human diseases.
model
Oklahoma researchers win $2.16 million grant to use 3D model to study lung virus
RSV is the leading cause of viral bronchiolitis and pneumonia worldwide, infecting more than 50 percent of children in their first year of life and nearly 100 percent by age 2.
Oblato acquires all rights to glioblastoma drug from OMRF
Oblato, Inc., has acquired all rights from OMRF to OKN-007, an investigational drug for the treatment of a deadly form of brain cancer.
OMRF researchers identify genes that may cause cancer to recur after treatment
Cancer often returns after successful therapy, but why?
OMRF researchers identify gene mutation present in pair of diseases
OMRF researchers found mutations in PDGF receptor beta can trigger two rare diseases.
OMRF receives grant to study triggers of cancer, birth defects
OMRF has received a five-year, $1.7 million grant to look at how DNA replicates itself.
